Litigation Details for SALIX PHARMACEUTICALS, LTD. v. SANDOZ INC. (D.N.J. 2019)
✉ Email this page to a colleague
SALIX PHARMACEUTICALS, LTD. v. SANDOZ INC. (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-09-30 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-05-12 |
| Cause | 35:271 Patent Infringement | Assigned To | Mitchell Goldberg (EDPA) |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Parties | BAUSCH HEALTH IRELAND LTD. | ||
| Patents | 10,456,384; 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275; 8,158,644; 8,158,781; 8,193,196; 8,309,569; 8,518,949; 8,741,904; 8,835,452; 8,853,231; 9,271,968 | ||
| Attorneys | CHARLES H. CHEVALIER | ||
| Firms | Eric I. Abraham | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SALIX PHARMACEUTICALS, LTD. v. SANDOZ INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for SALIX PHARMACEUTICALS, LTD. v. SANDOZ INC. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-09-30 | 1 | Complaint | of United States Patent Nos.7,045,620 (the “’620 patent”); 7,612,199 (the “’199 patent”); 7,902,206 (the…infringed one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275…infringe one or more claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,… C. A judgment that United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275…to the expiration date of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275 | External link to document |
| 2019-12-15 | 15 | Amended Complaint | the “’231 patent”); 9,271,968 (the “’968 patent”); and 10,456,384 (the “’384 patent”) (collectively, …8,741,904; 8,835,452; 8,853,231; 9,271,968; and 10,456,384 by submitting ANDA No. 213713 seeking FDA approval…8,741,904; 8,835,452; 8,853,231; 9,271,968; and 10,456,384 under 35 U.S.C. §§ 271(a), (b), (c), and/or (…8,741,904; 8,835,452; 8,853,231; 9,271,968; and 10,456,384 remain valid and enforceable; …8,741,904; 8,835,452; 8,853,231; 9,271,968; and 10,456,384, inclusive of any exclusivities and extensions | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
